LB Pharmaceuticals Valuation Multiples

LB Pharmaceuticals Overview

About LB Pharmaceuticals

LB Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. It is building a pipeline that leverages the broad therapeutic potential of its lead product candidate, LB-102, which the company believes has the potential to be the first benzamide antipsychotic drug approved for neuropsychiatric disorders in the United States. LB-102 is a new chemical entity and a methylated derivative of amisulpride, a second-generation antipsychotic drug approved in over 50 countries.

Founded

2015

HQ

Employees

16

Website

lbpharma.us

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

Net Income: ($47M)

EV

$294M

Valuation Multiples

Multiples.vc

Start free trial

LB Pharmaceuticals Financials

LB Pharmaceuticals reported last 12-month revenue of —.

In the same LTM period, LB Pharmaceuticals generated — in gross profit and had net loss of ($47M).

LB Pharmaceuticals P&L

In the most recent fiscal year, LB Pharmaceuticals reported revenue of — and EBITDA of ($30M).

LB Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

LB Pharmaceuticals Stock Performance

LB Pharmaceuticals has current market cap of $605M, and enterprise value of $294M.

LB Pharmaceuticals' stock price is $23.92.

LB Pharmaceuticals Valuation Multiples

LB Pharmaceuticals trades at (9.8x) EV/EBITDA.

LB Pharmaceuticals Financial Valuation Multiples

As of March 29, 2026, LB Pharmaceuticals has market cap of $605M and EV of $294M.

Equity research analysts estimate LB Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LB Pharmaceuticals has a P/E ratio of (12.9x).

LB Pharmaceuticals Margins & Growth Rates

LB Pharmaceuticals' revenue in the last fiscal year grew by —.

LB Pharmaceuticals' revenue per employee in the last FY averaged $0.0M.

LB Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

LB Pharmaceuticals M&A Activity

LB Pharmaceuticals acquired XXX companies to date.

Last acquisition by LB Pharmaceuticals was on XXXXXXXX, XXXXX. LB Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

LB Pharmaceuticals Investment Activity

LB Pharmaceuticals invested in XXX companies to date.

LB Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. LB Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).